Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ethics of Informed Consent with Comprehension of Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma.

Acta scientific cancer biology·2026
Same author

ASO Visual Abstract: Optimal Timing of Adjuvant Therapy for Patients with Poorly Differentiated Pancreatic Adenocarcinoma.

Annals of surgical oncology·2026
Same author

Optimal Timing of Adjuvant Therapy in Patients with Poorly Differentiated Pancreatic Adenocarcinoma.

Annals of surgical oncology·2026
Same author

"Horses out of the barn": pancreatic ductal adenocarcinoma frequently extends beyond the grossly visible tumour, requiring microscopic rectification for accurate T-staging.

Histopathology·2026
Same author

Intersection of Black race and carbohydrate antigen 19-9 nonproduction underpins worse pathologic response to neoadjuvant therapy in pancreatic cancer.

Cancer·2025
Same author

Intratumoral Heterogeneity of Ki67 Index and Its Impact on the Diagnosis and Prognostication of Pancreatic Neuroendocrine Tumors: Hot-Spot Count Differs Significantly from Random-Area Count.

Endocrine pathology·2025

Related Experiment Video

Updated: May 2, 2026

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
04:50

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Published on: January 17, 2025

995

Distal cholangiocarcinoma.

Neha Lad1, David A Kooby1

  • 1Division of Surgical Oncology, Department of Surgery, Winship Cancer Institute, Emory University School of Medicine, 1365C Clifton Road, Northeast, Atlanta, GA 30322, USA.

Surgical Oncology Clinics of North America
|February 25, 2014
PubMed
Summary
This summary is machine-generated.

Early diagnosis of distal cholangiocarcinoma is challenging, requiring improved methods. Achieving margin-negative resection and effective adjuvant therapy are key for better patient outcomes.

Keywords:
Distal cholangiocarcinomaNeoadjuvant therapyNodal dissectionSurgical resection

More Related Videos

Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma
05:22

Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma

Published on: February 13, 2026

254
Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma
09:19

Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma

Published on: July 14, 2022

4.9K

Related Experiment Videos

Last Updated: May 2, 2026

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
04:50

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Published on: January 17, 2025

995
Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma
05:22

Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma

Published on: February 13, 2026

254
Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma
09:19

Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma

Published on: July 14, 2022

4.9K

Area of Science:

  • Gastroenterology and Hepatobiliary Surgery
  • Oncology
  • Surgical Pathology

Background:

  • Distal cholangiocarcinoma (CCA) is a rare but aggressive biliary tract cancer.
  • Early diagnosis of distal CCA is difficult, often leading to advanced-stage presentation.
  • Current diagnostic modalities lack sufficient accuracy for early-stage detection.

Purpose of the Study:

  • To highlight the challenges in early diagnosis of distal cholangiocarcinoma.
  • To emphasize the critical role of surgical resection and adjuvant therapies in improving outcomes.
  • To identify areas for future research to enhance perioperative and long-term patient survival.

Main Methods:

  • Review of current literature on distal cholangiocarcinoma diagnosis and treatment.
  • Analysis of prognostic factors influencing patient survival.
  • Evaluation of the impact of neoadjuvant therapy and surgical techniques.

Main Results:

  • Margin-negative resection and complete nodal dissection are the strongest prognostic indicators.
  • Surgical resection combined with adjuvant therapy offers the most favorable outcomes.
  • Advances in medical and neoadjuvant therapies show potential to improve surgical candidacy and outcomes.

Conclusions:

  • Improved diagnostic accuracy is crucial for early detection of distal cholangiocarcinoma.
  • Optimal management involves margin-negative surgical resection and adjuvant therapy.
  • Future research should focus on reducing surgical complications and enhancing medical therapies for better patient outcomes.